Cardiff Oncology, Inc. earnings per share and revenue

CRDF earnings per share for the last quarter are -0.21 USD whereas the estimation was -0.27 USD which accounts for 21.36% surprise. Company revenue for the same period amounts to 156.00 k USD despite the estimated figure of 50.00 k USD. Estimated earnings per share for the next quarter are -0.25 USD, and revenue is expected to reach 62.50 k USD. Also watch annual changes over time to get a bigger picture of CRDF earnings per share and revenue dynamics.